Literature DB >> 22498226

Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens.

Andrew S Y Huo1, Tania Hossack, James L P Symons, Ruth PeBenito, Warick J Delprado, Phillip Brenner, Phillip D Stricker.   

Abstract

PURPOSE: We determined whether systematic template guided transperineal biopsies can accurately locate and sensitively detect prostate cancer. In addition, we reported discrepancies between diagnostic and pathological Gleason scores, and investigated whether prostate size had an effect on the cancer detection rate.
MATERIALS AND METHODS: This retrospective diagnostic accuracy study compares the results of primary transperineal biopsies with the radical prostatectomy pathology of 414 consecutive patients treated at a single institution between November 2002 and August 2010.
RESULTS: The average sensitivity and specificity for the detection of cancer in all prostates across all biopsy zones was 48% (95% CI 42.6-53.4) and 84.1% (95% CI 80-88.2), respectively. There was a statistically significant decrease in the sensitivity of transperineal biopsy in larger prostates (t11=4.687, p=0.001). The overall Kappa value was 0.255 (95% CI 0.212-0.298). Grading concordance between biopsy and pathology specimens was achieved in 65.7% of patients. Upgrading of Gleason scores occurred in 25.6% of patients and downgrading occurred in 8.8%.
CONCLUSIONS: Our current transperineal biopsy method has only demonstrated fair agreement with the histopathology findings of the corresponding radical prostatectomy specimens. This finding is most likely due to the small, multifocal nature of prostate cancer in the patient series. The cancer detection rate was lower in larger prostates. Thus, clinicians may consider increasing the number of cores in larger prostates as a strategy to improve cancer detection.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22498226     DOI: 10.1016/j.juro.2012.01.066

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Prostate cancer: Localized disease-are most men really suitable for focal therapy?

Authors:  Ben Challacombe; Luke Dixon
Journal:  Nat Rev Urol       Date:  2013-12-10       Impact factor: 14.432

2.  Advantages of single-puncture transperineal saturation biopsy of prostate: analysis of outcomes in 125 patients using our scheme.

Authors:  Eugenio Martorana; Salvatore Micali; Ahmed Ghaith; Luca Reggiani Bonetti; Maria Chiara Sighinolfi; Riccardo Galli; Maurizio Paterlini; Giampaolo Bianchi
Journal:  Int Urol Nephrol       Date:  2015-04-08       Impact factor: 2.370

3.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.

Authors:  Frank-Jan H Drost; Daniël F Osses; Daan Nieboer; Ewout W Steyerberg; Chris H Bangma; Monique J Roobol; Ivo G Schoots
Journal:  Cochrane Database Syst Rev       Date:  2019-04-25

Review 4.  Can we deliver randomized trials of focal therapy in prostate cancer?

Authors:  Hashim U Ahmed; Viktor Berge; David Bottomley; William Cross; Rakesh Heer; Richard Kaplan; Tom Leslie; Chris Parker; Clare Relton; Richard Stephens; Matthew R Sydes; Lindsay Turnbull; Jan van der Meulen; Andrew Vickers; Timothy Wilt; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2014-04-22       Impact factor: 66.675

Review 5.  Considerations for patient selection for focal therapy.

Authors:  John F Ward; Louis L Pisters
Journal:  Ther Adv Urol       Date:  2013-12

6.  Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy.

Authors:  Yoshiro Sakamoto; Kaori Fukaya; Masaki Haraoka; Kosuke Kitamura; Yoichiro Toyonaga; Michio Tanaka; Shigeo Horie
Journal:  Prostate Int       Date:  2014-06-17

Review 7.  Limitations and Prospects for Diffusion-Weighted MRI of the Prostate.

Authors:  Roger Bourne; Eleftheria Panagiotaki
Journal:  Diagnostics (Basel)       Date:  2016-05-27

8.  Analysis of preoperative detection for apex prostate cancer by transrectal biopsy.

Authors:  Tomokazu Sazuka; Takashi Imamoto; Takeshi Namekawa; Takanobu Utsumi; Mitsuru Yanagisawa; Koji Kawamura; Naoto Kamiya; Hiroyoshi Suzuki; Takeshi Ueda; Satoshi Ota; Yukio Nakatani; Tomohiko Ichikawa
Journal:  Prostate Cancer       Date:  2013-02-21

Review 9.  The role of focal therapy in the management of localised prostate cancer: a systematic review.

Authors:  Massimo Valerio; Hashim U Ahmed; Mark Emberton; Nathan Lawrentschuk; Massimo Lazzeri; Rodolfo Montironi; Paul L Nguyen; John Trachtenberg; Thomas J Polascik
Journal:  Eur Urol       Date:  2013-06-06       Impact factor: 20.096

10.  Discordance between location of positive cores in biopsy and location of positive surgical margin following radical prostatectomy.

Authors:  Ji Won Kim; Hyoung Keun Park; Hyeong Gon Kim; Dong Yeub Ham; Sung Hyun Paick; Yong Soo Lho; Woo Suk Choi
Journal:  Korean J Urol       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.